CLINICAL_TRIALS
trial_result
· 2009-10-07
Clinical Trial Update: Tiotropium / Respimat One-Year Study [Phase 3]
Summary
A Phase 3 one-year study of tiotropium delivered by Respimat in chronic obstructive pulmonary disease has completed and posted results. The update provides long…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2009-10-07